Amedisys

Traded on the St. Petersburg Stock Exchange
Amedisys is a leading healthcare at home Company delivering personalized home health, hospice and personal care. More than 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care.
Amedisys stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Amedisys balance sheet

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Amedisys cash flows

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Amedisys multipliers

Report period2018 2019 2020 2021 20222023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Amedisys profitability

Report period2018 2019 2020 2021 20222023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Amedisys assets
Amedisys cash flows

Amedisys shares

TickerNameTypeNominal valueISINPrice
AMED:USAmedisys, Inc.Common share-US0234361089$92.15
Amedisys news
27.04.2022
Net income of Amedisys under GAAP for the 3 months of 2022 was $31.713 million, down 36.9% from $50.292 million in the previous year. Revenue increased 1.5% to $545.257 million from $537.144 million a year earlier.
Source: {source} pictogram investors.amedisys.com
Pictogram next
24.02.2022
Net income of Amedisys under GAAP for 2021 was $210.166 million, up 13.5% from $185.184 million in the previous year. Revenue increased 6.9% to $2.214 billion from $2.072 billion a year earlier.
Source: {source} pictogram investors.amedisys.com
Pictogram next
03.11.2021
Amedisys reported a GAAP net profit of $176.156 million for 9M 2021, up 26.1% from $139.604 million in the previous year. Revenue increased by 8.8% to $1.655 billion from $1.521 billion a year earlier.
Source: {source} pictogram investors.amedisys.com
Pictogram next
04.08.2021
Amedisys' GAAP net income for the six months of 2021 was $130.911 million, up 94.8% from $67.193 million in the previous year. Revenues increased 12.8% to $1.101 billion from $0.976 billion a year earlier.
Source: {source} pictogram investors.amedisys.com
Pictogram next
All Amedisys news
General information
Company nameAmedisys
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services
Business address3854 AMERICAN WAY SUITE A BATON ROUGE LA 70816 2252922031
Mailing address3854 AMERICAN WAY SUITE A BATON ROUGE LA 70816
Websitewww.amedisys.com
Information disclosurewww.sec.gov